These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21925445)

  • 1. [Analysis of therapeutic compliance in women with osteoporosis].
    Carbonell Abella C; Guañabens Gay N; Regadera Anechina L; Marín Rives JA; Taverna Llauradó E; Ayechu Redín MP;
    Reumatol Clin; 2011; 7(5):299-304. PubMed ID: 21925445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observational study of treatment compliance in women initiating antiresorptive therapy with or without calcium and vitamin D supplements in Spain.
    Díez A; Carbonell C; Calaf J; Caloto MT; Nocea G
    Menopause; 2012 Jan; 19(1):89-95. PubMed ID: 21934533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported compliance with osteoporosis medication-qualitative aspects and correlates.
    Vytrisalova M; Blazkova S; Palicka V; Vlcek J; Cejkova M; Hala T; Pavelka K; Koblihova H
    Maturitas; 2008; 60(3-4):223-9. PubMed ID: 18774663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge and compliance from patients with postmenopausal osteoporosis treatment.
    Palacios S; Sánchez-Borrego R; Neyro JL; Quereda F; Vázquez F; Pérez M; Pérez M
    Menopause Int; 2009 Sep; 15(3):113-9. PubMed ID: 19723681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compliance with osteoporosis treatment guidelines in postmenopausal women.
    Mountjoy CR; Shrader SP; Ragucci KR
    Ann Pharmacother; 2009 Feb; 43(2):242-50. PubMed ID: 19196838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
    Rosa J; Vanuga P; Payer J; Svobodník A
    Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric properties of the Osteoporosis-specific Morisky Medication Adherence Scale in postmenopausal women with osteoporosis newly treated with bisphosphonates.
    Reynolds K; Viswanathan HN; O'Malley CD; Muntner P; Harrison TN; Cheetham TC; Hsu JW; Gold DT; Silverman S; Grauer A; Morisky DE
    Ann Pharmacother; 2012 May; 46(5):659-70. PubMed ID: 22510666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates.
    McHorney CA; Schousboe JT; Cline RR; Weiss TW
    Curr Med Res Opin; 2007 Dec; 23(12):3137-52. PubMed ID: 17988435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinant factors of osteoporosis patients' reported therapeutic adherence to calcium and/or vitamin D supplements: a cross-sectional, observational study of postmenopausal women.
    Sanfelix-Genovés J; Gil-Guillén VF; Orozco-Beltran D; Giner-Ruiz V; Pertusa-Martínez S; Reig-Moya B; Carratalá C
    Drugs Aging; 2009; 26(10):861-9. PubMed ID: 19761279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Initial treatment trends in patient with osteoporosis: use of antiresorptive agents and pharmacologic supplements (calcium and vitamin D) in clinical practice].
    Carbonell C; Díez A; Calaf J; Caloto MT; Nocea G; Lara N
    Reumatol Clin; 2012; 8(1):3-9. PubMed ID: 22118802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician and patient perceptions on the use of vitamin D and calcium in osteoporosis treatment: a European and Latin American perspective.
    Resch H; Walliser J; Phillips S; Wehren LE; Sen SS
    Curr Med Res Opin; 2007 Jun; 23(6):1227-37. PubMed ID: 17559732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of medication adherence on health care utilization and productivity: self-reported data from a cohort of postmenopausal women on osteoporosis therapy.
    Wade SW; Satram-Hoang S; Nadkar A; Macarios D; Tosteson AN
    Clin Ther; 2011 Dec; 33(12):2006-15. PubMed ID: 22099387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis pharmacotherapy and counseling services in US ambulatory care clinics: opportunities for multidisciplinary interventions.
    Teschemaker A; Lee E; Xue Z; Wutoh AK
    Am J Geriatr Pharmacother; 2008 Dec; 6(5):240-8. PubMed ID: 19161926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium and vitamin D intake by postmenopausal women with osteoporosis in France.
    Czernichow S; Fan T; Nocea G; Sen SS
    Curr Med Res Opin; 2010 Jul; 26(7):1667-74. PubMed ID: 20446889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical strategies to address patients' concerns in osteoporosis management with bisphosphonates.
    Cole RE
    Postgrad Med; 2011 Mar; 123(2):131-44. PubMed ID: 21474901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the cost effectiveness of bisphosphonates in the treatment of post-menopausal osteoporosis in Switzerland.
    Lippuner K; Pollock RF; Smith-Palmer J; Meury T; Valentine WJ
    Appl Health Econ Health Policy; 2011 Nov; 9(6):403-17. PubMed ID: 21910511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence to medical treatment of osteoporosis in women at three different clinical settings--a historical cohort study.
    Nielsen DS; Langdahl BL; Sørensen OH; Sørensen HA; Brixen KT
    Scand J Public Health; 2010 Jul; 38(5):502-7. PubMed ID: 20484306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Undertreatment of osteoporosis in regional Western Australia.
    Lai MM; Ang WM; McGuiness M; Larke AB
    Australas J Ageing; 2012 Jun; 31(2):110-4. PubMed ID: 22676170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician perception of patient adherence compared to patient adherence of osteoporosis medications from pharmacy claims.
    Copher R; Buzinec P; Zarotsky V; Kazis L; Iqbal SU; Macarios D
    Curr Med Res Opin; 2010 Apr; 26(4):777-85. PubMed ID: 20095797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.